Dean Kamen

Dean Kamen is an inventor, an entrepreneur, and a tireless advocate for science and technology. His  passion for innovation has driven groundbreaking advancements in healthcare, mobility, and education,  shaping industries and inspiring future generations. 

Kamen is the founder of DEKA Research & Development Corporation, FIRST® (For Inspiration and  Recognition of Science and Technology), FIRST Global, and the Advanced Regenerative Manufacturing  Institute (ARMI) | BioFabUSA. 

Supported by the U.S. Department of Defense, ARMI is a national Manufacturing Innovation Institute and nonprofit organization focused on building a competitive, capable, and innovative domestic ecosystem  for cell, tissue, and organ manufacturing. Under Kamen’s leadership, ARMI and its nearly 200 members  nationwide are integrating expertise in biomanufacturing, medicine, and engineering to de-risk and  accelerate the development of regenerative therapies that will revolutionize healthcare for chronic illness and traumatic injury. 

As president of DEKA, he has developed category-defining, transformational innovations to include:  revolutionary drug delivery systems – as with the twiist™ Automated Insulin Delivery System and the  Remunity® pump which safely delivers stable doses of Remodulin; mobility systems that restore health  and quality of life – as with the iBOT™ Mobility System, and the LUKE robotic arm; devices that change  the healthcare paradigm – as with cardiac stents, the HomeChoice™ portable dialysis machine; and  innovations that change what the world believes is possible – as with a new and improved Stirling engine.

In addition to DEKA, one of Kamen’s proudest accomplishments is founding FIRST®, an organization  dedicated to motivating the next generation to understand, use and enjoy science and technology –and  to apply it for societal contribution. Founded in 1989, FIRST® serves more than 2,500,000 young people  ages 6 to 18 annually. He expanded this initiative to create FIRST Global, which last year united teams  from over 190 countries to its annual competition in Athens, Greece. 

Kamen’s contributions have earned him numerous honors, including the National Medal of Technology in 2000, presented by President Bill Clinton. He was elected to the National Academy of Engineering in  1997, awarded the Lemelson-MIT Prize in 2002, and inducted into the National Inventors Hall of Fame in 2005. He is also a Fellow of the American Institute for Medical and Biological Engineering. 

Wednesday
May 07
Universal Immunity
1:45 PM

-

2:15 PM

Imagine a world where infectious diseases can be neutralized before they become global threats—where immunity isn't reactive, but universal. This session explores groundbreaking advancements in biotechnology, rapid-response platforms, and global health strategies that aim to provide immediate protection against emerging pathogens. From engineered antibodies and synthetic vaccines to decentralized diagnostics and equitable healthcare distribution, join the conversation on how science, innovation, and collaboration could revolutionize humanity's defense against the next pandemic.

Wednesday
May 07
The Future of American Bioinnovation
2:25 PM

-

2:55 PM

Join an engaging fireside chat exploring the future landscape of bioinnovation, where visionary ideas meet real-world applications. Discover how cutting-edge technologies in synthetic biology, healthcare, and biomanufacturing are reshaping our world—from regenerative medicine and organ engineering to accessible global healthcare solutions. Learn how interdisciplinary collaboration, creativity, and bold entrepreneurial thinking are driving breakthroughs that promise not only to transform human health but also redefine what it means to innovate for impact.

Conference Pass

2,495

USD

Keynotes & Firesides

Workshops & Breakouts

1:1 Partnering App

Meals & Receptions

Session Recordings

Until Friday April 18th

Full Rate:

$3,495

Other Speakers

Copyright SynBioBeta 2025